ArticleFrontiers in oncology2022

GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide.

Sweta Parik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.